EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity.

EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity.
复制标题

DOI:
10.1021/acsmedchemlett.5b00037
复制
发表时间:
2015-05-14
影响因子:
4.2
通讯作者:
Copeland, Robert A.
Copeland, Robert A.
中科院分区:
医学3区
文献类型:
--
作者:
Campbell, John E.;Kuntz, Kevin W.;Knutson, Sarah K.;Warholic, Natalie M.;Keilhack, Heike;Wigle, Tim J.;Raimondi, Alejandra;Klaus, Christine R.;Rioux, Nathalie;Yokoi, Akira;Kawano, Satoshi;Minoshima, Yukinori;Choi, Hyeong-Wook;Scott, Margaret Porter;Waters, Nigel J.;Smith, Jesse J.;Chesworth, Richard;Moyer, Mikel P.;Copeland, Robert A.

文献摘要

参考文献

被引文献

相似文献

Zeste同源物2(EZH2)的蛋白甲基转移酶增强子的抑制剂可具有治疗B细胞淋巴瘤和其它癌症适应症的显著治疗潜力。科学界充分探索EZH2相关病理生物学谱的能力由于缺乏这种酶的体内活性工具化合物而受到阻碍。在这里,我们报告了EPZ011989的发现和表征,EPZ011989是一种有效的、选择性的、口服生物可利用的EZH2抑制剂,具有有用的药代动力学特性。EPZ 011989在人B细胞淋巴瘤的小鼠异种移植模型中显示出显著的肿瘤生长抑制作用。因此,这种化合物代表了在生物学中扩大EZH2活性探索的有力工具。
Inhibitors of the protein methyltransferase Enhancer of Zeste Homolog 2 (EZH2) may have significant therapeutic potential for the treatment of B cell lymphomas and other cancer indications. The ability of the scientific community to explore fully the spectrum of EZH2-associated pathobiology has been hampered by the lack of in vivo-active tool compounds for this enzyme. Here we report the discovery and characterization of EPZ011989, a potent, selective, orally bioavailable inhibitor of EZH2 with useful pharmacokinetic properties. EPZ011989 demonstrates significant tumor growth inhibition in a mouse xenograft model of human B cell lymphoma. Hence, this compound represents a powerful tool for the expanded exploration of EZH2 activity in biology.
DOI: 10.1038/nm.2651
发表时间: 2012-02-06
期刊: Nature medicine
影响因子: 82.9
作者:
通讯作者: --
DOI: 10.1021/ml400494b
发表时间: 2014-04-01
影响因子: 4.2
作者:
Nasveschuk, Christopher G.;Gagnon, Alexandre;Harmange, Jean-Christophe P.
通讯作者: Harmange, Jean-Christophe P.
DOI: 10.1126/science.1076997
发表时间: 2002-11-01
期刊: SCIENCE
影响因子: 56.9
作者:
Cao, R;Wang, LJ;Zhang, Y
通讯作者: Zhang, Y
DOI: 10.1101/gad.1035902
发表时间: 2002-11-15
影响因子: 10.5
作者:
Kuzmichev, A;Nishioka, K;Reinberg, D
通讯作者: Reinberg, D
DOI: 10.1073/pnas.1012525107
发表时间: 2010-12-07
影响因子: 11.1
作者:
Sneeringer, Christopher J.;Scott, Margaret Porter;Copeland, Robert A.
通讯作者: Copeland, Robert A.